Stocksigma LogoStocksigma Logo

Transgene Biotek Board Meeting on 13th Nov'26 for Q2 Financial Results

Transgene Biotek Limited has scheduled a Board of Directors meeting on 13th Nov'26 to consider and approve the standalone and consolidated un-audited

Transgene Biotek Board Meeting on 13th Nov'26 for Q2 Financial Results

Transgene Biotek Ltd 路 Intimation 路 13 Nov 2026, 5:30 am

Transgene Biotek Board Meeting on 13th Nov'26 for Q2 Financial Results Transgene Biotek Limited has scheduled a Board of Directors meeting on 13th Nov'26 to consider and approve the standalone and consolidated un-audited financial results and limited review report for the quarter and half-year ended 30th Sep'26. The board will also evaluate the re-appointment of Dr. K. Koteswara Rao as Chairman and Managing Director for a one-year term, subject to shareholder approval. Additionally, the board will finalize the notice, Board鈥檚 Report, record date, book closure, and e-voting schedule for the 36th Annual General Meeting.

Original exchange filing (PDF)

More announcements from Transgene Biotek Ltd

All Transgene Biotek Ltd announcements